Author:
Høberg-Vetti Hildegunn,Bjorvatn Cathrine,Fiane Bent E,Aas Turid,Woie Kathrine,Espelid Helge,Rusken Tone,Eikesdal Hans Petter,Listøl Wenche,Haavind Marianne T,Knappskog Per M,Haukanes Bjørn Ivar,Steen Vidar M,Hoogerbrugge Nicoline
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference35 articles.
1. Ferlay J, Soerjomataram I, Ervik M et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from http://globocan.iarc.fr (accessed on 07 July 2015).
2. Kurian AW : BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 2010; 22: 72–78.
3. Zhang S, Royer R, Li S et al: Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol 2011; 121: 353–357.
4. Alsop K, Fereday S, Meldrum C et al: BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol 2012; 30: 2654–2663.
5. Song H, Cicek MS, Dicks E et al: The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population. Hum Mol Genet 2014; 23: 4703–4709.
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献